By Lu Wang
Aug. 31 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses.
Airgas Inc. (ARG US): The biggest U.S. distributor of industrial gases will replace Cooper Industries Ltd. (CBE US) in the Standard & Poor’s 500 Index, S&P said in a statement.
Bristol-Myers Squibb Co. (BMY US): AstraZeneca Plc’s (AZN US) experimental clot-fighting drug Brilinta prevented 16 percent more heart attacks, strokes and deaths than standard therapy with Sanofi-Aventis SA’s (SNY US) and Bristol-Myers Squibb’s Plavix in a study.
Broadcom Corp. (BRCM US): The maker of semiconductors for wireless headsets and television set-top boxes said in entered a partial settlement of shareholder derivative lawsuits. Broadcom said it would receive about $118 million from directors and officers liability insurers, if the settlement is approved.
Expeditors International of Washington Inc. (EXPD US): The company that buys and resells bulk cargo space on ships and planes may rise 20 percent or more as the global economy recovers, Barron’s said.
Ford Motor Co. (F US): The company, seeking labor concessions granted to U.S. rivals, is working to bridge a gap with the United Auto Workers amid union resistance to a second round of 2009 givebacks, people familiar with the talks said.
Johnson Controls Inc. (JCI US): The largest U.S. auto-parts supplier may rise as increasing demand for energy-efficient cars and buildings boosts its earnings, Barron’s said, citing analysts.
Hillenbrand Inc. (HI US): The largest U.S. maker of coffins may rise as the economy rebounds and consumers spend more on funerals and cremation products, Barron’s said, citing analysts.
Pacer International Inc. (PACR US): The provider of trucking, freight and transportation logistics services said it entered into an amended and restated credit agreement with its syndicate of financial institutions.
Tessera Technologies Inc. (TSRA US): The designer of packaging for computer chips lost a U.S. trade ruling in its efforts to get new licensing revenue from makers of computer- memory chips.
Watson Pharmaceuticals Inc. (WPI US): The drugmaker said it received approval from the U.S. Food and Drug Administration on its abbreviated new drug application for Levonorgestrel day- after contraceptive tablets for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
To contact the reporter on this story: Lu Wang in New York at lwang8@bloomberg.net.
Posts
No comments:
Post a Comment